Gilead Sciences | Pasivo Circulante


Current Liabilities Cambio
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
ALKERMES ALKS:US $ 438.52M 23.84M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Glaxosmithkline GSK:US $ 37835M 13557M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
YTE INCY:US $ 926.67M 40.51M



Gilead Sciences Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2022.